Access Oncology Licenses Zentaris’ Anticancer Compound
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 29 (Table of Contents)
Published: 2 Oct-2002
DOI: 10.3833/pdr.v2002.i29.993 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Access Oncology and Zentaris AG, a subsidiary of Degussa AG entered into licensing and co-development agreement for Zentaris’ perifosine for the treatment of tumors...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS